Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Category Archives: Public Health

Subscribe to Public Health RSS Feed

2013 – Scripps/Cornell Team Advance HIV Researsch

Posted in Drug Studies

Human immunodeficiency virus (HIV) infects more than 34 million people worldwide.  HIV is a virus that causes acquired immunodeficiency syndrome (AIDS), a condition, which does not allow the immune system to fight off other lethal infections.  HIV. The immune system functions by recognizing proteins on the surface of viruses and bacteria.  HIV is unique in… Continue Reading

Anti-seizure drug Onfi linked to serious skin conditions

Posted in Safety Alerts

Seizures are potentially dangerous episodes resulting from abnormal neuronal activity in the brain.  Several medications have been created to prevent these episodes from occurring.  One such Anti-seizure medication is called Onfi, which is a schedule IV (CIV) oral antiepileptic.  Onfi has also been linked to some very harmful side effects, which has prompted the FDA… Continue Reading

Pacific Trade Agreement and Risks for US Food Safety

Posted in Politics, Public Health

The United States is currently working to sign the Trans Pacific Partnership (TPP), a 12-nation trade agreement that by eliminating “tariffs and other barriers to goods and services trade and investment”, may result in risks for food safety in the US, says Democratic Congresswoman Rosa DeLauro (CT). According an interview with Julian Hattem of RegWatch,… Continue Reading

Research Shows: Presence of Bacteria in the Gut are Important in Combating Cancer

Posted in Drug Studies

Published Thursday, scientists at the National Cancer Institute wrote an article called “NIH Mouse Study Finds Gut Microorganisms May Determine Cancer Treatment Outcomes”.  The National Cancer Institute believes they may have found a connection between the presence of certain organisms living in the human gut and the success of cancer therapy.  Mice that had cancerous… Continue Reading

FBI Steps Up Defenses for Attacks on US Food Supply

Posted in FDA Regulation, Public Health

Ellen Beck recently wrote an article for the “Smart Blog on Food and Beverage” website titled “FBI Makes Threats to U.S. Food Supply a Bigger Priority”, that discusses the food industry’s vulnerability to intentional food contamination.  In light of all the terrorist attacks taking place throughout the world, the FBI is becoming increasingly concerned that… Continue Reading

FDA approves new cancer drug Crizotinib

Posted in Drug Studies, Public Health

In an article published from the Oncology Report Digital Network by Elizabeth Mechcatie, titled “FDA Grants Full Approval to Crizotinib for NSCLC Indication”, the Food and Drug Administration announced that a new drug was approved for the treatment of small cell lung cancer.  Crizotinib is a kinase inhibitor that works by blocking the actions of… Continue Reading

Reuters: Curis Places Testing of New Cancer Drug On Hold

Posted in Drug Studies

Last Wednesday (11/6/2013), Reuters reported that the approval of a new cancer drug by Curis Inc. has stalled after a patient died while taking the drug. Curis Inc. is a company that develops many new drugs used for in cancer treatment.  In collaboration with other major drug companies, Curis created Erivedge, the only medication for… Continue Reading

WARNING: FDA recall on OxyElite Pro due to connection with “serious adverse health consequences, namely serious liver damage or acute liver failure”

Posted in Public Health, Recalls

On 11-9-2013, the FDA announced a recall of dietary supplement OxyElite Pro (USPlabs LLC, Dallas) “after officials linked it to cases of liver failure and acute hepatitis in 29 people” in Hawaii, CNN reports. Several sources now report that one of two patients who required liver transplants has died.  WebMD writes that other people “are… Continue Reading

FDA moves to ban trans fats – New York Times

Posted in FDA Regulation, Public Health

A November 7th New York Times article by Sabrina Tavernise discusses the recent FDA ruling surrounding trans fats. Nutrition is an ever-changing area of research.  Many of the guides to healthy cooking and eating methods once thought ideal are now seen to be quite unhealthy and harmful to our health.  During the 1950’s, 1960’s, and… Continue Reading

FDA seeks more stringent controls for some pain medications

Posted in FDA Regulation, Public Health

According to a recent report by HealthToday.com, The U.S. Food and Drug Administration believes certain commonly-used drugs that should be more difficult to obtain.  Painkillers such as Lortab and Vicodin contain hydrocodone (a synthetic opiate) which is often abused and highly addictive; tighter controls on these types of prescriptions may be a good way to… Continue Reading

E. Coli Outbreak in Knox County, Tennessee

Posted in Public Health

A Knox County, Tennessee dairy farm has recently come under harsh scrutiny since an E. coli outbreak hit Mascot last Thursday.  Health officials have reported that a few children have become sick from the E. coli outbreak and that the proper authorities will contact anyone who may have exposed.  Investigators collected samples from the farm… Continue Reading

Maine Passes Law Allowing Importation of Potentially Fake Pharmaceuticals

Posted in Politics, Public Health

The wide range of tools the internet can provide has proven problematic in the regulation of prescription drugs that are sold from online pharmaceutical companies based in foreign countries.  Counterfeit drugs have exploded onto the scene and as reported by Forbes, the worldwide market for these drugs is estimated to be worth 75 billion dollars…. Continue Reading

Boston Salads Recall for Listeria Contamination

Posted in Public Health

Due to a possible contamination with Listeria monocytogenes, Boston Salads and Provisions Company is recalling 222,959 pounds of ready to eat chicken salad products.  As reported by FoodSafetyNews.com, the contaminaited chcken salad prodcuts in question were made August 23rd, 2013 to October 14th, 2013 and were shipped to wholesalers in Massachusetts and New Hampshire.  Despite… Continue Reading

New Cancer Drug Ramucirumab (Eli Lilly & Co.) Prioritized by FDA

Posted in Drug Studies

Headquartered in Indianapolis, Indiana, Eli Lilly and Company is a pharmaceutical company with offices all over the world.  Recently, the company developed a single-agent treatment for gastric cancer; a drug called Ramucirumab.  Ramucirumab is used if cancer continues to progress after initial chemotherapy.  And according to a report published 10-24-2013 by PharmaceuticalBusinessReview.com, the company recently… Continue Reading

Salmonella Outbreak in California

Posted in Public Health, Safety Alerts

On October 11th, the US Centers for Disease Control and Prevention reported that 317 people have become sick across the country in a recent outbreak of salmonella “tied to a California poultry producer.”  As reported by the American Association for Justice, “nearly half of the cases required hospitalization” and about three-quarters of the cases have… Continue Reading

2013 – CDC: Salmonella Outbreak Sickens 317 in 20 States

Posted in Public Health, Safety Alerts

On October 11th, the US Centers for Disease Control and Prevention reported that 317 people have become sick across the country in a recent outbreak of salmonella “tied to a California poultry producer.”  As reported by the American Association for Justice, “nearly half of the cases required hospitalization” and about three-quarters of the cases have… Continue Reading

Oil leak concerns after Colorado floods

Posted in Public Health

As if the recent Colorado floods that claimed eight innocent lives, forced thousands from their homes, and caused over $2 billion in property damage had not been sufficiently catastrophic, the New York Times now reports that 37,000 gallons of oil have spilled due to “swamped wells, broken pipes and [flood waters sweeping] huge oil tanks… Continue Reading

FDA Recall Safety Alert: Siemens MicroScan Synergies plus® and MicroScan® rapID/S plus Negative Panels

Posted in Recalls, Safety Alerts

On August 21st, the US Food and Drug Administration issued a Class-1 recall for Siemens MicroScan Synergies plus® and MicroScan® rapID/S plus Negative Panels, affecting “78,020 panels distributed in the US between 07/11/2011 and 08/02/2013.” (FDA) These panels come as part of kits used by medical professionals to test a patient’s saliva or tissue for… Continue Reading

FDA: “Fluoroquinolone Antibacterial Drugs: Drug Safety Communication- Risk for possibly permanent nerve damage”

Posted in Cipro, Safety Alerts

Cipro (ciprofloxacin), an antibiotic that has recently been linked to retinal detachment and other nerve disorders, came under fire last week as the US Food and Drug Administration rules that new warnings and usage guidelines be included on its packaging “to better describe the serious side effect of peripheral neuropathy”[1] or, nerve damage. MedlinePlus, an… Continue Reading

Olympia Pharmacy (FL) recalls “all sterile drug products”

Posted in Recalls

Citing concerns about sterility, Lowlite Investments (d/b/a Olympia Pharmacy) in Orlando, FL has recently recalled “all sterile drug products compounded by the pharmacy that have not reached the expiration date listed on the product,” according to a recent FDA report. With respect to the present concern over the safety of products sold as sterile by… Continue Reading

ER visits from illegal ADD drug use quadruples in recent years

Posted in Public Health

A recent New York times article has reported that “The number of young adults who end up in the emergency room after taking Adderall, Ritalin or other such stimulants has quadrupled in recent years,” according to “federal health officials.” This data comes from a report by the Substance Abuse and Mental Health Services Association (SAMHSA),… Continue Reading

Nationwide FDA Recall: ‘All sterile products’ from Specialty Compounding

Posted in Recalls

On August 11th of this year, the United States Food and Drug Administration issued a “nationwide recall of all products produced and distributed for sterile use by Specialty Compounding, LLC, Cedar Park, TX.  There have been recent reports of bacterial bloodstream infections potentially related to the company’s calcium gluconate infusions.”[1] So far, “The FDA has… Continue Reading

FDA: Tylenol linked to rare, dangerous skin condition

Posted in Safety Alerts

On August 1st, the FDA issued a safety alert for acetaminophen, the main ingredient in Tylenol and other painkillers, based on new data that has shown exposure to the drug can trigger several rare but dangerous skin reactions. An excerpt from the FDA report: “These skin reactions [associated with acetaminophen], known as Stevens-Johnson Syndrome (SJS),… Continue Reading

FDA: Victoza Investigated for Possible Cancer Link

Posted in Safety Alerts

WARNING: FDA TO INVESTIGATE VICTOZA-CANCER LINK Recently, the FDA has moved to evaluate whether or not Victoza (liraglutide), a drug used in GLP-1 therapy for the treatment of type II diabetes is associated with an increased rate for cancer. Victoza and other GLP-1 therapy drugs have been previously linked to asymptomatic pancreatitis, and it is… Continue Reading